PD-L1 monoclonal antibody (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-L1 monoclonal antibody (unspecified), covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy as Bridge Therapy to Liver Transplantation for Locally Advanced Perihilar Cholangiocarcinoma (ACHIEVE-LT) [Phase 2]